AN2 Therapeutics
next unblind phase data | AN2 Therapeutics
Company
Deck Type
Sector
Industry
Deck date
February 2025
Slide
15 of 36
Similar slides by AN2 Therapeutics
See diffirences between slides (animation)
Investor Presentation
March 2025
next unblind phase data | AN2 Therapeutics
Related slides by other companies
Larimar Therapeutics
Investor Presentation
November 2023
repeated subcutaneous injections of were generally well tolerated in phase mad trial | Larimar Therapeutics
RenovoRx
IPO
August 2021
designed for success one phase trial to approval pivotal tiger pac phase study schema currently enrolling | RenovoRx
MAIA Biotechnology
Investor Presentation
November 2023
thio trial planned a | MAIA Biotechnology
MindMed
Investor Presentation
November 2024
key highlights of program | MindMed
Other recent decks by AN2 Therapeutics
See all presentations (4 decks)
Investor Presentation
March 2025
Investor Presentation
August 2022
IPO
March 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2024 Slidebook.io